Ambagon Therapeutics

Drug DiscoveryWebsite

Developer of small-molecule cancer drugs designed to stabilize the direct interaction of oncogenic proteins. The company's drugs selectively augment the endogenous tumor suppression activity of protei...

Drug Discovery
Healthcare
Eindhoven, Netherlands
Founded 2019
37 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$108M
Last Round
Early Stage VC (Series A)
Jan 2022
Latest Funding Round
Early Stage VC (Series A)
Jan 5, 2022
$85M
raised
View all funding rounds
Investors
+12 other investors
View all 12 investors
Valuation History
1 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Ambagon Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required